Literature DB >> 27665515

SAVE trial: no cardiovascular benefits for CPAP in OSA.

Bryant Furlow.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27665515     DOI： 10.1016/S2213-2600(16)30300-9

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  3 in total

1.  Breath-holding as a means to estimate the loop gain contribution to obstructive sleep apnoea.

Authors:  Ludovico Messineo; Luigi Taranto-Montemurro; Ali Azarbarzin; Melania D Oliveira Marques; Nicole Calianese; David P White; Andrew Wellman; Scott A Sands
Journal:  J Physiol       Date:  2018-07-06       Impact factor: 5.182

2.  Sleep-disordered breathing in patients with cardiovascular diseases cannot be detected by ESS, STOP-BANG, and Berlin questionnaires.

Authors:  Hannes Reuter; Simon Herkenrath; Marcel Treml; Marcel Halbach; Daniel Steven; Konrad Frank; Alessandra Castrogiovanni; Ilona Kietzmann; Stephan Baldus; Winfried J Randerath
Journal:  Clin Res Cardiol       Date:  2018-05-29       Impact factor: 5.460

Review 3.  Environmental Factors as Modulators of the Relationship between Obstructive Sleep Apnea and Lesions in the Circulatory System.

Authors:  Dominika Urbanik; Helena Martynowicz; Grzegorz Mazur; Rafał Poręba; Paweł Gać
Journal:  J Clin Med       Date:  2020-03-19       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.